The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist
- Eur J Pharmacol. 1995 Aug 25;282(1-3):R3-4. doi: 10.1016/0014-2999(95)00460-3.
- 1. Unité de Neurobiologie et Pharmacologie de l'INSERM, Centre Paul Broca, Paris, France.
In a NG 108 15 hybrid cell line stably expressing a recombinant dopamine D3 receptor, (+)-UH 232 (cis-(+)-1S,2R)-5-methoxy-1-methyl-2-(di-n- propylamino)tetralin), a partially selective D3 receptor ligand, stimulates mitogenesis, as measured by incorporation of [3H]thymidine, with an EC50 of 7.6 nM and a maximal increase corresponding to 23% of the response elicited by quinpirole, a full agonist. This effect was antagonised by nafadotride, a D3 receptor-selective antagonist. (+)-UH 232 also antagonised quinpirole-induced mitogenesis with a Ki value of 9.4 nM. (+)-UH 232 (1 microM) inhibited by 22% the forskolin-induced accumulation of cAMP, whilst the inhibition by quinpirole (100 nM) was 53%. These results indicate that (+)-UH 232 is a partial agonist at the D3 receptor with an intrinsic activity of 0.2-0.4.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Dopamine ReceptorResearch Areas: Neurological Disease